Replies to post #7187 on Momenta Pharmaceuticals, Inc. (MNTA)

[HattieTheWitch]

(Hattie)

Are you suggesting that the presumed huge dropoff in income will not be nearly as steep as some (including me) expect?

(go seek)

yes, consider (high probability) a-enox will not be on the market. and SNY has little to no incentive to push the AG without an a-enox launch.

Yes, but doesn't the "hybrid" (or whatever the new royalty payment method is called) payment, by itself, severely reduce MNTA's "take", regardless of SNY's sales?

IOW, regardless of how much or how little SNY sells, I thought MNTA's income from m-enox would drop considerably. Am I wrong?

Thank you.